glycopyrrolate · Sumitomo Pharma Am · NDA 208437
Lonhala Magnair Kit
Earliest generic entry, as listed
7 Dec 2036
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 10744277.
Listed patents · 8 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10744277 | drug product, use U-2941 · sets the listed date | 7 Dec 2036 |
| US 10688518 | drug product | 12 Nov 2036 |
| US 10376661 | drug product | 14 Sep 2035 |
| US 9604018 | drug product | 16 May 2033 |
| US 9168556 | drug product | 1 Sep 2032 |
| US 9789270 | drug product | 30 Oct 2030 |
| US 10940110 | drug product, use U-1773 | 26 Feb 2029 |
| US 9265900 | drug product | 7 Dec 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 208437 · 001 · RLD · discontinued | solution, inhalation | 25MCG/ML | 7 Dec 2036 |
Expired or delisted (1)
- US 11278683 · product · 16 Aug 2026